Late-onset calcinosis in burn scars: A review of the literature and two case reports.

Calcinosis cutis is a heterotopic accumulation of calcium salts in the skin. It has been described as a late-onset complication of burn scars in a few cases, in contrast to heterotopic ossification, which may be an early-onset complication of burn injuries. Diagnosis of calcinosis can be confirmed by radiography, ultrasonography, computed tomography, magnetic resonance imaging or histology. Almost all cases of late-onset calcinosis in burn scars present as non-healing ulcers on the lower extremities near contracture bands. It has been hypothesized that this localization is due to the more frequent microtrauma of the lower extremities, and that ulceration is due to the presence of calcium deposits as foreign bodies. In our study, the mean age at the time of burn injury was 12.5 ± 8.27 years, and calcinosis developed after a mean time of 37.5 ± 14.95 years (mean age at onset was 50.5 ± 14.53 years). There was no significant difference between burn scars managed with skin grafting and those where skin grafting was not carried out. The ulcers healed after resection or extraction of the deposits without any recurrence at the same site. In contrast to previously reported cases, we observed two cases of non-ulcerating late-onset calcinosis in burn scars of the upper extremities.

Introduction

Calcinosis is a heterotopic accumulation of calcium salts (hydroxyapatite crystals and amorphous calcium phosphate) [1] in soft tissues. It can be subdivided into four subtypes. The dystrophic subtype is caused by calcium deposition in areas of tissue damage (e.g. trauma, connective tissue diseases, neoplasms); the metastatic subtype is due to altered calcium and phosphate homeostasis; the iatrogenic subtype is an undesirable side effect of medical care (e.g. extravasation of calcium‐containing solutions), and the idiopathic subtype is of unknown origin. The most common subtype is the dystrophic one, especially calcinosis related to autoimmune connective tissue diseases [1]. Calcinosis has also been reported as a rare, late‐onset complication of extensive burn scars [2]. It may be classified as dystrophic calcification in the absence of alterations in serum calcium and phosphate levels. The diagnosis of burn scar calcinosis may be confirmed by radiography, ultrasonography, computed tomography, magnetic resonance imaging or histology.

In this paper, we review case reports and review articles related to burn‐associated calcification that were available in English on the Pubmed®, Scopus®, Web of Science®, and Google Scholar® databases, and provide a meta‐analysis of the patient data. The articles included in this work contain relevant data on burn calcinosis cases. Reports of ossification after burns and accounts where the term “calcinosis” was used inconsistently as a synonym for “ossification” were excluded. The following keywords were searched for: calcinosis, calcification, soft tissue calcification, burn, burn scar, and burn keloid.

Epidemiology

The exact epidemiology of calcinosis is still unknown. Kolár et al. reported a 3.3 % incidence of early‐onset calcinosis occurring within five weeks to two years after burns [3]. Munster et al. observed a high incidence of early‐onset calcification of the arms in a prospective study, with a frequency of 22 % of third‐degree burns and 2.4 % without third‐degree burns. This high incidence was probably due to the fact that it incorporated spontaneously resolving lesions, which were the vast majority of cases. In this early‐onset calcinosis group, radiological evidence of calcification was noted 48 days post‐burn on average, and no histological examinations were performed. There was no significant alteration of serum calcium levels, but there was a significant reduction in serum alkaline phosphatase levels in patients who had calcinosis. There was no significant correlation with the burned surface area or immobilization of the patients after trauma, but there was a significant correlation with burn depth and limitation of mobility of adjacent joints [4]. In contrast to calcinosis, where amorphous calcium salt deposits are present, heterotopic ossification with bone tissue formation is a complication of burn scars in 1.25–13.6 % of cases, mainly periarticular on the upper extremities [4, 5, 6, 7, 8, 9, 10]. This usually occurs weeks to months after sustaining burn injuries [11, 12].

Pathogenesis

Soft tissue calcification differs fundamentally from soft tissue ossification [11], and calcification is usually not converted into bone formation (Figure 1) [10]. The pathomechanism and risk factors of calcium deposition in burn injuries are unknown. Presumably, in dystrophic calcification local trauma, chronic inflammation or tissue hypoxia may precipitate the calcifying process in the presence of local promoters and systemic mediators that decrease the level of calcification inhibitors, such as pyrophosphate or fetuin A [13, 14]. Damaged or altered collagen, elastin, and subcutaneous fat promote calcification, and phosphate‐bound denatured proteins of necrotic cells serve as a nidus for ectopic calcification [1]. Furthermore, the cell membrane cannot maintain the normal low concentration of intracellular calcium and phosphate; this results in the uptake of these ions and hydroxyapatite formation in the mitochondria. During the propagation phase, these hydroxyapatite crystals grow in size [15]. The precipitation of calcium salts may be due to the increased alkalinity of necrotic tissues.

Figure 1

Pathophysiology of dystrophic calcification and ossification.

In heterotopic ossification, mesenchymal stem cells undergo osteogenic differentiation; burn injury causes an upregulation of osteogenic gene signaling [16]. Venous stasis, inflammation, or connective tissue disease may lead to the release of bone morphogenetic proteins (BMPs), which are growth factors [11, 17]. Inducing agents such as BMPs serve as promoting factors that can cause osteogenic differentiation of mesenchymal stem cells in a permissive environment. Osteoblasts are stimulated by various factors such as hypercalcemia, hypoxia, parathormone and calcitonin disequilibrium, decreased levels of ossification inhibitors, immobilization and changes in sympathetic nerve activity [18, 19]. Risk factors for burn‐associated ossification include body surface burns greater than 30 % in area, arm burns, and skin grafting of arms after thermal injury [7].

Diagnosis and differential diagnosis

Diagnoses of burn scar calcinosis may be confirmed by radiography, ultrasonography, computed tomography, magnetic resonance imaging or histology. Three‐phase bone scintigraphy may be applied to distinguish calcinosis from ossification [11, 12]. During ossification, osteoblasts, osteoclasts, and osteoid formation can be identified with histopathology. This is in contrast to calcinosis, where amorphous calcium deposits appear as fine granules in the dermis and as large irregular masses in the subcutis; these are stained dark blue with hematoxylin and eosin and black with von Kossa [20, 21]. In the differential diagnosis of burn scar calcinosis, ossification, keloidal and hypertrophic scars should be considered, and it may be necessary to rule out scar carcinoma with histopathology (Figure 2).

Figure 2

Two entities requiring differential diagnosis of calcinosis associated with burn injury. Burn scar keloid on the arm without calcification (a). Verrucous carcinoma in a burn scar of the forearm (b).

Cases of late‐onset burn scar calcinosis

Only a few cases of late‐onset burn scar calcinosis have been reported in the literature (Table 1). Almost all of these presented as non‐healing ulcers on the lower extremities in or near contracture bands several years after the burn trauma. Calcium and phosphate levels were within the normal range. In some cases, a white coloration of the overlying skin was observed, presumably due to more severe scarring or translucency of the whitish calcium deposits [15]. Some authors hypothesize that involvement of the lower extremities is caused by more frequent microtrauma of these body parts, and that ulceration is due to the calcium deposit present as a foreign body [22].

Table 1

Demographic and treatment data of late‐onset burn scar calcinosis patients

Sex	Age at onset (years)	Age at burn (years)	Time interval (years)	Skin grafting after burn	Location of calcinosis	Ulceration	Therapy	Follow‐up (months)	Result (same site)	Author, year
M	66	29	37	N	LE	Y	E	36	NR	Beninson et al. 1964 [24]
M	36	9	27	Y	LE	Y	E	24	NR	Beninson et al. 1964 [24]
F	58	8	50	Y	LE	Y	S	ND	NR	Hogan et al. 1964 [25]
F	46	26	20	N	LE	Y	E, triamcinolone il.	ND	NR	Coskey et al. 1984 [26]
M	42	17	25	N	LE	Y	S, split skin graft	36	NR	Ebrahim et al. 2003 [15]
M	35	10	25	Y	LE	Y	S	36	NR	Ebrahim et al. 2003 [15]
M	48	18	30	Y	LE	Y	S	24	NR	Ebrahim et al. 2003 [15]
M	28	8	20	Y	LE	Y	S, split skin graft	30	NR	Ebrahim et al. 2003 [15]
M	31	2	29	N	LE	Y	E	ND	NR	Choi et al. 2003 [29]
M	44	14	30	N	A	Y	E	6	NR	Lee et al. 2005 [22]
F	76	22	54	N	UE	Y	E	LFU	NR	Lee et al. 2005 [22]
F	42	3	39	N	H	N	ND	ND	NR	Sokhn et al. 2009 [23]
M	57	15	42	N	LE	Y	S	6	NR	Rosmaninho et al. 2015 [2]
F	52	12	40	N	LE	Y	S, skin graft	4	NR	Moon et al. 2 018 [27]
M	59	ND	ND	Y	LE	Y	S	36	NR	Lockwood et al. 2018 [28]
F	65	4	61	N	UE, B	N	S	108	NR	Róbert et al.
F	74	3	71	N	UE	N	S	LFU	ND	Róbert et al.

Abbr: A, abdomen; B, back; E, deposit extraction; F, female; H, head; il., intralesional; LE, lower extremity; LFU, lost to follow‐up; M, male; N, no; ND, no data; NR, no recurrence; S, surgical excision; UE, upper extremity; Y, yes.

In contrast to the cases reported earlier, we present two cases of burn scar calcinosis of the upper extremities without ulceration. To the best of our knowledge, only one case of non‐ulcerating late‐onset burn scar calcinosis has been reported (Sokhn et al.); this was located on the right cheek of a female patient 39 years of age after a burn injury sustained at the age of three [23].

Our first case is a 65‐year‐old woman without any relevant comorbidities, who suffered a burn injury on her arms and back at the age of four. Sixty‐one years later, she presented at our department with infiltration and hyperkeratosis of the scar keloid in the left scapular region (Figure 3). Histopathological examination was performed to exclude scar carcinoma; this revealed keloid with dystrophic calcification (Figure 4). Six years later she presented with a calcified nodule on her left forearm (Figure 5), which was confirmed radiologically and excised (Figure 6). Serum calcium and phosphate levels were within the normal range. There was no recurrence of the calcified lesions, and no ulceration developed during a follow‐up period of nine years.

Figure 3

Calcified nodule in a burn scar of the left scapular region in a 65‐year old female patient, 61 years after burn trauma (a). Greater magnification of the same nodule (b).

Figure 4

Histological image of calcinosis in a burn scar, with purple‐stained calcified deposits on the right side of the image (hematoxylin and eosin, scale bar: 200 μm).

Figure 5

Calcinosis in a burn scar of the left upper extremity in a 65‐year old female patient 67 years after the burn trauma (a). Greater magnification of the same burn scar (b).

Figure 6

Radiograph of dense calcinosis in a burn scar of the left upper extremity.

Our second case is a 74‐year‐old woman without any relevant comorbidities or serum calcium and phosphate level abnormalities, who suffered a burn injury of her right arm at the age of three. Seventy‐one years later she presented at our department with a radiologically proven calcium deposit in the right forearm keloid, which was excised. The patient was lost to follow‐up.

We took data from the 15 cases reported in the literature as well as our own two cases (male : female = 10 : 7) [2, 15, 22–29]. In the literature cases, twelve patients had calcinosis on the lower extremities (including the buttocks), one on the upper extremity, one on the abdomen and one on the face. Both of our two cases had calcinosis on the upper extremities (including the scapular region). The mean age at onset was 50.5 ± 14.53 years (range 28–76) in total, 44.6 ± 12.75 (range 28–66), and 59 ± 13.28 (range 42–76) years between males and females respectively. Mean age at the time of the burn was 12.5 ± 8.27 years (range 2–29) in total, 13.5 ± 7.67 (range 2–29), and 11.1 ± 9.42 (range 3–26) years between males and females respectively. Mean time to onset of calcinosis was 37.5 ± 14.95 (range 20–71), 29.4 ± 6.62 (range 20–42), and 47.8 ± 16.67 (range 20–71) years in total, between males and females respectively. If we consider only the ulcerating calcinosis cases, the mean age was 48.4 ± 13.81, 44.6 ± 12.75, and 58 ± 12.96 years, in total, males and females, respectively. Mean age at the time of the burn was 14.6 ± 7.72, 13.5 ± 7.67, and 17 ± 8.4 years, mean time interval was 33 ± 10.85, 29.4 ± 6.62, and 41 ± 15.19 years, in total, males and females respectively. Mean age in the non‐ulcerating group was 60.3 ± 16.5 years at onset, 3.3 ± 0.58 years at burn, and mean time to onset was 57 ± 16.37 years.

Therapy of calcinosis

There is no accepted therapeutic algorithm for the management of calcinosis. Recommendations are based on case reports and retrospective studies of small populations of mainly dystrophic calcinosis related to autoimmune connective tissue diseases. For solitary lesions, surgical excision is recommended [30, 31], especially if the trigger factor is no longer present, or if excision is expected to be curative (e.g. calcifying neoplasms) [32]. Carbon dioxide laser [33] and extracorporeal shock wave lithotripsy [34, 35] may also be applied [36]. With regard to burn scar calcinosis, almost all the cases reported in the literature were managed with surgical monotherapy. To the best of our knowledge, the only exception was intralesional triamcinolone administered as an adjunct to surgical excision in individual cases [26]. Considering that systemic medications may not achieve sufficient penetration into the scar tissue and that there are no other data regarding pharmacotherapy for burn scar calcinosis, medications that were administered in other forms of dystrophic calcinosis (mainly calcinosis associated with autoimmune connective tissue diseases) cannot be recommended as first‐line treatment. These agents include the calcium channel‐blocker diltiazem [30, 31], bisphosphonates [30, 37, 38], probenecid [30, 39, 40], aluminum hydroxide [30, 41], warfarin [42], ceftriaxone [43], intravenous immunoglobulin [44, 45, 46], topical sodium‐thiosulphate [47, 48, 49] and, for inflamed lesions, colchicine [31, 50], minocycline [30, 51], thalidomide [52], intralesional corticosteroids [53, 54] and rituximab [36, 55]. The pharmacotherapy of calcinosis is not discussed in detail in this paper.

Concerning late‐onset calcinosis following burn injuries, there was no significant difference between burn scars managed with skin grafting after the trauma and scars where skin grafting was not carried out. This suggests that remaining surgical material such as sutures are unlikely to play a role in the development of calcification. Ulcers healed after resection or extraction of the calcified deposits without any recurrence at the same site. In some cases, if there was no wide excision or skin grafting, a new lesion developed at another site – probably due to an earlier microcalcification that was not removed [2, 22, 29]. This suggests that silent microcalcification may be relatively frequent in burn scars.

Discussion

Interestingly, all the three patients who were reported to have non‐ulcerating calcinosis sustained the burn injury in their early childhood (at ages of three to four) and none had lesions on a lower extremity, only on an upper extremity and face. This may be explained by the location, which is less exposed to recurrent microtrauma, or a more complete tissue repair in early childhood, which prevented the formation of deposits. Calcinosis generally developed later in female patients than in male patients. Given the small population, far‐reaching conclusions cannot be drawn.

Based on data in the literature and our own experience with management of burn scar calcinosis, we recommend laboratory testing to rule out calcium metabolism deficits and excision of calcified ulcers with direct closure or skin grafting, or removal of the calcified deposits [15, 22]. Recurrence may occur if small deposits remain, since these can lead to ulceration and chronic inflammation [22, 56]. Follow‐up of patients is recommended due to the possibility of recurrence and malignant transformation of chronic ulcers.

Conclusions

Dystrophic calcinosis can develop in each type of tissue alteration or trauma. Late‐onset calcinosis in burn scars is a rare variant that differs in its pathophysiology from ossification, which is a slightly more common complication of burn injuries with real ectopic bone formation. Late‐onset burn scar calcinosis presents as non‐healing ulcers in lower extremities in most cases, and this may lead to increased susceptibility to infections and other complications. Removal of calcified nodules is advisable in order to prevent undesirable consequences. The efficacy of drug therapy for burn scar calcinosis is likely to be limited, because pharmaceuticals do not reach adequate concentrations in the scar tissue. This requires further research.

Conflict of interest

None.